Cargando…

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients

Detalles Bibliográficos
Autores principales:	Benotmane, Ilies, Gautier Vargas, Gabriela, Velay, Aurélie, Wendling, Marie-José, Perrin, Peggy, Fafi-Kremer, Samira, Caillard, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800460/ https://www.ncbi.nlm.nih.gov/pubmed/33370503 http://dx.doi.org/10.1111/ajt.16469

Ejemplares similares

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
por: Benotmane, Ilies, et al.
Publicado: (2022)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022)

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
por: Velay, Aurelie, et al.
Publicado: (2020)

Prédiction de la sévérité de la COVID-19 par les biomarqueurs du syndrome de relargage cytokinique au sein d’une population de transplantés rénaux
por: Benotmane, I., et al.
Publicado: (2020)

Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study
por: Muller, Clotilde, et al.
Publicado: (2016)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
por: Gallais, Floriane, et al.
Publicado: (2021)

Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia
por: Solis, Morgane, et al.
Publicado: (2022)

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism
por: Felten, Renaud, et al.
Publicado: (2019)

L’immunosuppression et le défaut d’immunogénicité des vaccins à ARNm limitent la protection des patients transplantés vaccinés selon le schéma standard : plaidoyer pour une 3(e) dose
por: Charmetant, X., et al.
Publicado: (2021)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

Tick-Borne Encephalitis in Pregnant Woman and Long-Term Sequelae
por: Velay, Aurélie, et al.
Publicado: (2023)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection
por: Barth, Heidi, et al.
Publicado: (2016)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

COVID-19 and kidney transplantation
por: Caillard, Sophie
Publicado: (2022)

Antigen specificities of HIV-infected cells: A role in infection and persistence?
por: Faua, Clayton, et al.
Publicado: (2023)

Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay
por: Drouot, Laurent, et al.
Publicado: (2020)

Complications neurologiques du COVID-19 chez les patients atteints de maladie rénale
por: Perrin, P., et al.
Publicado: (2020)

COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France
por: Velay, Aurélie, et al.
Publicado: (2022)

An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides
por: Domingo-Calap, Pilar, et al.
Publicado: (2018)

Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients
por: Arroyo, David, et al.
Publicado: (2014)

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
por: Gallais, Floriane, et al.
Publicado: (2021)

Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
por: Gueguen, Juliette, et al.
Publicado: (2022)

Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds
por: Meyer, Maxence, et al.
Publicado: (2022)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
por: Garrouste, Cyril, et al.
Publicado: (2016)

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination
por: Garcia, Laura, et al.
Publicado: (2022)

Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients
por: Cremoni, Marion, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sv65ccdj5kigtl6ffi9uv0ne6e